In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...
At 24 months overall survival was 62.8% with Welireg plus Lenvima versus 55.4% with Cabometyx. Median overall survival was 34 ...
The bus is designed to expand access to lifesaving, next-generation treatments across nearly 70,000 square miles of ...
The new "Advanced Therapies Bus" is equipped to perform both leukapheresis and stem cell collections on board. It is intended to expand access across thousands of square miles of South Texas, with ...
SINGAPORE, March 5, 2026 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT) today announced the launch of its ...
Chimeric antigen receptor T (CAR-T) cell therapy has emerged as a transformative approach in modern medicine, demonstrating remarkable efficacy in targeting pathogenic B-cell lineages with ...
GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired a majority interest in Aurion Biotech, Inc., ...
Cell therapy manufacturers approach autologous therapy manufacturing in multiple ways, with point-of-care manufacturing, academic projects embedded within major medical centers, and centralized ...
Johnson & Johnson, the healthcare and lifestyle giant announced a more than $1 billion dollar investment in next generation cell therapy ...
Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials In this pilot study, we assessed the ...
DUBLIN--(BUSINESS WIRE)--The "Cell and Gene Therapy CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results